Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Hepatology (Baltimore, Md.)
|
December 19, 2013
How does met regulate the survival/apoptosis balance?
Alessandro Furlan, David Tulasne
Elife
|
April 23, 2024
Recording and classifying MET receptor mutations in cancers
Célia Guérin, David Tulasne
BMB Reports
|
January 24, 2019
Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase
Marie Fernandes, Leslie Duplaquet, David Tulasne
European Journal of Biochemistry
|
March 5, 2002
Regulation of RAS in human platelets. Evidence that activation of RAS is not sufficient to lead to ERK1-2 phosphorylation
David Tulasne, Teresa Bori, Steve P Watson
Biochemical and Biophysical Research Communications
|
October 15, 2016
The caspase-generated cleavage product of Ets-1 p51 and Ets-1 p27, Cp17, induces apoptosis
Souhaila Choul-Li, David Tulasne, Marc Aumercier
Medecine Sciences : M/S
|
October 15, 2014
[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies]
Rémi Montagne, Alessandro Furlan, Zoulika Kherrouche, et al.
Oncogene
|
May 25, 2021
When the MET receptor kicks in to resist targeted therapies
Marie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Cancer Research
|
November 21, 2014
Thirty years of research on met receptor to move a biomarker from bench to bedside
Alessandro Furlan, Zoulika Kherrouche, Rémi Montagne, et al.
Bulletin Du Cancer
|
November 20, 2016
[MET receptor inhibition: Hope against resistance to targeted therapies?]
Audrey Hochart, Pierre Leblond, Xuefen Le Bourhis, et al.
Annals of the New York Academy of Sciences
|
December 18, 2002
Involvement of RAS-ERK signaling in multiple biological responses to HGF/SF
David Tulasne, Rejane Paumelle, Catherine Leroy, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Hepatology (Baltimore, Md.)
|
December 19, 2013
How does met regulate the survival/apoptosis balance?
Alessandro Furlan, David Tulasne
Elife
|
April 23, 2024
Recording and classifying MET receptor mutations in cancers
Célia Guérin, David Tulasne
BMB Reports
|
January 24, 2019
Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase
Marie Fernandes, Leslie Duplaquet, David Tulasne
European Journal of Biochemistry
|
March 5, 2002
Regulation of RAS in human platelets. Evidence that activation of RAS is not sufficient to lead to ERK1-2 phosphorylation
David Tulasne, Teresa Bori, Steve P Watson
Biochemical and Biophysical Research Communications
|
October 15, 2016
The caspase-generated cleavage product of Ets-1 p51 and Ets-1 p27, Cp17, induces apoptosis
Souhaila Choul-Li, David Tulasne, Marc Aumercier
Medecine Sciences : M/S
|
October 15, 2014
[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies]
Rémi Montagne, Alessandro Furlan, Zoulika Kherrouche, et al.
Oncogene
|
May 25, 2021
When the MET receptor kicks in to resist targeted therapies
Marie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Cancer Research
|
November 21, 2014
Thirty years of research on met receptor to move a biomarker from bench to bedside
Alessandro Furlan, Zoulika Kherrouche, Rémi Montagne, et al.
Bulletin Du Cancer
|
November 20, 2016
[MET receptor inhibition: Hope against resistance to targeted therapies?]
Audrey Hochart, Pierre Leblond, Xuefen Le Bourhis, et al.
Annals of the New York Academy of Sciences
|
December 18, 2002
Involvement of RAS-ERK signaling in multiple biological responses to HGF/SF
David Tulasne, Rejane Paumelle, Catherine Leroy, et al.
Page
of 7